Xcout IntelSign inSubscribe

DIMERIX LIMITED

DXBPharmaceuticals, Biotechnology & Life SciencesFitzroy, Australia

Dimerix Limited is an Australian biopharmaceutical firm dedicated to discovering and bringing to market innovative pharmaceutical solutions for medical conditions where existing treatments are insufficient. The company's leading therapeutic candidate, DMX-200, is currently undergoing extensive clinical evaluation, including two separate Phase 3 trials targeting respiratory complications linked to COVID-19. DMX-200 is also in a distinct Phase 3 clinical trial for focal segmental glomerulosclerosis (FSGS), a severe kidney disorder, and is being developed for the treatment of diabetic kidney disease. Additionally, Dimerix is advancing DMX-700, which is intended for chronic obstructive pulmonary disease (COPD). The company's corporate headquarters are located in Fitzroy, Australia.

Subscribe to see DIMERIX LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

DIMERIX LIMITED at a glance

DIMERIX LIMITED is a pharmaceuticals, biotechnology & life sciences company headquartered in Fitzroy, Australia. It is publicly listed (DXB) with a market capitalisation of $130.2M. Xcout tracks 8 named people at DIMERIX LIMITED, including Nina Webster (Chief Executive Officer / Managing Director).

Industry
Pharmaceuticals, Biotechnology & Life Sciences
Headquarters
Fitzroy, Australia
Market cap
$130.2M
Employees
15
Ticker
DXB

DIMERIX LIMITED leadership

  • Nina WebsterChief Executive Officer / Managing Director
  • Robert ShepherdChief Operating Officer
  • Mike TonroeChief Financial Officer & Company Secretary
  • David FullerChief Medical Officer
  • Mark DiamondNon-Executive Chairman
  • Clinton SnowNon-Executive Director

2 more named people on record for DIMERIX LIMITED, with roles, board committees and tenure — see the full roster →

Get DIMERIX LIMITED's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

DIMERIX LIMITED — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on DIMERIX LIMITED in Xcout Intel

  • 8 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →